Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06060925 · ClinicalTrials.gov registry record
Imaging Biomarkers for Myofascial Pain
A clinical trial, sponsored by George Mason University.
- Completed
- Registry status
- 96
- Enrollment target
NCT06060925: Completed study, sponsored by George Mason University.
NCT06060925 is a clinical trial that has completed, run by George Mason University. The registered enrollment target is 96 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06060925 has completed, sponsored by George Mason University.
- COMPLETED
- Registry status
- 96 participants
- Enrollment target
Study Summary
Myofascial pain syndrome (MPS) is highly prevalent in the community. It is primarily diagnosed using patient self reports and physical examination, which lack reliability, sensitivity and specificity and does not provide insights into the abnormal biological and physiological processes in soft tissues. While a number of treatment methods are available to patients, there are currently no criteria to determine which treatments might be best for each patient's unique myofascial pain phenotype. To improve evidence-based management of myofascial pain, there is a critical need to develop quantitative measures that advance the understanding of the physiological processes in the underlying the soft tissues across the clinical continuum of MPS. The objective of this project is to develop a quantitative biomarker informed by the current understanding of underlying tissue-level mechanisms at the level of the "myofascial unit" (muscle, nerve, fascia, vasculature, lymphatics) that are likely to be involved in MPS.
Primary Outcome
Shear wave elastography utilizes the radiation force of ultrasound to induce shear waves in tissue and measure the propagation speed. It provides information about the mechanical properties of tissue. We will extract the shear anisotropy ratio as the outcome measure.
Interventions
- DIAGNOSTIC_TEST Ultrasound imaging
- DIAGNOSTIC_TEST Electromyography
- DIAGNOSTIC_TEST Physical examination
- DIAGNOSTIC_TEST Bioimpedance spectroscopy
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 96 participants |
| Start Date | 2023-01-01 |
| Est. Completion | 2025-08-31 |
What the finished NCT06060925 record still lists
NCT06060925 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 96 participants, a relatively small participant target.
The record links to 0 conditions, and to 4 interventions - of which Ultrasound imaging is the first listed.
NCT06060925 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06060925 about?
NCT06060925 is a clinical study titled "Imaging Biomarkers for Myofascial Pain". Myofascial pain syndrome (MPS) is highly prevalent in the community. It is primarily diagnosed using patient self reports and physical examination, which lack reliability, sensitivity and specificity and does not provide insights into the abnormal biological and physiological processes in soft tissu...
What is the current status of trial NCT06060925?
This trial is currently completed. The enrollment target is 96 participants. The study started on 2023-01-01. Estimated completion is 2025-08-31.
What interventions are being tested in trial NCT06060925?
The interventions under investigation include: Ultrasound imaging (DIAGNOSTIC_TEST), Electromyography (DIAGNOSTIC_TEST), Physical examination (DIAGNOSTIC_TEST), Bioimpedance spectroscopy (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT06060925?
This trial is sponsored by George Mason University, which has 25 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03401762 · 96 participants · NA
Wearable MCI to Reduce Muscle Co-activation in Acute and Chronic Stroke
- NCT03471260 · 96 participants · Phase 1
Ivosidenib and Venetoclax With or Without Azacitidine in Treating Patients With IDH1 Mutated Hematologic Malignancies
- NCT03549559 · 96 participants · NA
Imaging Histone Deacetylase in the Heart
- NCT03841058 · 96 participants · Phase 2
Abaloparatide vs. Placebo in Post-Menopausal Women and Abaloparatide in Men Receiving Initial Spinal Fusion Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI